Skip to content
Paragon Biosciences LLC
  • About Us
  • Our Approach
  • Portfolio
  • Leadership
  • Careers
  • Contact Us
  • News Room

ecopipam

2 items

  • December 15, 2020

    First Patient Dosed in Emalex Biosciences Phase 2 Clinical Trial for Stuttering

    Chicago – December 15, 2020 – Emalex Biosciences, [...]

  • September 1, 2020

    Emalex Biosciences Phase 2b Tourette Syndrome Clinical Trial Reaches Enrollment Milestone

    – Half of participants are now enrolled [...]

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611 |

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611

© 2026 Paragon Biosciences LLC
Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500
Chicago, IL 60611

Page load link
Go to Top